Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Lasers in Surgery and Medicine|January 17, 2012
The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related moleculesAlan Belicha-Villanueva, Jonah Riddell, Naveen Bangia, et al.
Immunologic Research|October 16, 2009
What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?Alan Belicha-Villanueva, Jennifer Blickwedehl, Sarah McEvoy, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virusBalaji Manicassamy, Santhakumar Manicassamy, Alan Belicha-Villanueva, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|January 24, 2008
Safety and efficacy of various combinations of injectable anesthetics in BALB/c miceSandra Buitrago, Thomas E Martin, Joanne Tetens-Woodring, et al.
Immunology|January 16, 2008
Differential contribution of TAP and tapasin to HLA class I antigen expressionAlan Belicha-Villanueva, Sarah McEvoy, Kelly Cycon, et al.
Human Immunology|July 6, 2010
Identification of an alternate splice form of tapasin in human melanomaAlan Belicha-Villanueva, Michelle Golding, Sarah McEvoy, et al.
Journal of Molecular Biology|January 2, 2014
Modulation of an ectodomain motif in the influenza A virus neuraminidase alters tetherin sensitivity and results in virus attenuation in vivoVictor H Leyva-Grado, Rong Hai, Fiona Fernandes, et al.
Journal of Virology|January 7, 2011
Budding capability of the influenza virus neuraminidase can be modulated by tetherinMark A Yondola, Fiona Fernandes, Alan Belicha-Villanueva, et al.
Oncology|August 21, 2008
Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenograftsKenji Sugamura, John F Gibbs, Alan Belicha-Villanueva, et al.
Journal of Virology|July 28, 2010
Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complexJuan R Rodriguez-Madoz, Alan Belicha-Villanueva, Dabeiba Bernal-Rubio, et al.
Pageof 2